Principle of open incisional biopsy
Incision: longitudinal incision for extension of incision for definitive management
Approach: don’t expose NV structures*
All tissue exposed during Bx = contaminated*
Biopsy: THROUGH INVOLVED COMPARTMENT***
Closure: if using drain, keep in line with incision to allow drain site to be removed w/ definitive surgical extensile incision***
Distal femur likely osteosarcoma –> which compartment to biopsy through?
Can biopsy through either anterior or lateral INTRAmuscular approach –> will resect at time of final operation
What does chemo induce in cancer cells?
Tyrosine kinase inhibitor?
Good prognostic sign for necrosis with chemo?
What ortho tumors need chemo?
Chemo induces APOPTOSIS***
Chemo may target specific proteins over expressed in cancer cells, ie tyrosine kinase inhibitors:
Imatinib (Gleevec) for CML
Geftinib/EGFR inhibitor for lung and breast
Ertlotinbi for NSCLC and pancreatic
Good prognostic = >98% necrosis with chemo**
Ortho tumors requiring chemo: Osteosarcoma*** Ewings*** MFH*** Dediff chondrosarc
issue with doxorubicin?
Cardiac toxicity*** –> CHF/caridomyopathy
use Dexrazoxane*** to mitigate toxicity
Mirel Criteria
Site
UE = 1
LE = 2
Peritroch = 3
Pain
Mild = 1
Moderate = 2
Severe/functional = 3
Lesion
Blastic = 1
Mixed = 2
Lytic = 3
Size
<1/3 = 1
1/3-2/3 = 2
> 2/3 = 3
Score >/= to 8 –> prophylactic fixation***
If lower than this consider XRT***
What type of bony met has the worst prog?
Lung cancer and melanoma***
Enneking/MSTS staging system
One for malignant and one for benign lesions
Malignant = defined by Roman numerals (I, II, III)
Osteosarc most commonly stage IIB***
Benign = Arabic numerals (1, 2, 3) 1= latent lesion, enchondroma or NOF 2= active lesion, ABC/UBC, chondroblastoma, GCT 3= aggressive lesion, GCT (some)
Stage IA = low grade, T1/intracompartmental (bone tumor confined within cortex***)/ no mets
Stage IIB = low grade, T2/extracompartmental (bone tumor extends beyond cortex)/no mets
Stage IIA: High grade, T1/intracompratmental/no mets
Stage IIB: High grade, T2/extracompartmental/no mets
Stage III = mets
Where will osteoid osteoma be in spine?
Why are osteoid osteomas painful?
Size?
Histology?
Posterior elements***
Concavity of scoliosis***
Pain 2/2 PROSTAGLANDIN E2*** and Cox 1 and 2 expression –> pain relieved by NSAIDs
Size generally <1.5 cm –> otherwise think osteoblastoma***
Histo: distinct demarcation between nidus and reactive bone*
Nidus: immature osteoid/woven bone with sharp border of osteoblastic rimming
Uniform plump osteoblasts have regularly shaped nuclei w/ abundant cytoplasm (indicating benign lesion)*
Where to NOT perform RF ablation for osteoid osteoma?
Spine (neural elements close)
Fingers (thermal necrosis to overlying skin and NV elements)
What is most common malignancy of bone?
Primary malignancy of bone?
Primary sarcoma of bone?
Most common overall: mets
Most common primary malignancy of bone: multiple myeloma
Most common primary sarcoma of bone: intramedullary osteosarcoma
Intramedullary osteosarcoma
Where does occur in skeleton?
Where does metastasize to?
What stage present at most commonly?
Genetics?
Long term survival?
Occurs in distal femur and prox tibia most commonly***
Also in humerus, proximal femur and pelvis
Mets: lung most common, bone 2nd most common
Stage presents at: stage IIB most commonly (10-20% stage III with lung mets**)
Genetics: Rb carriers are at risk of osteosarcoma
Risk increased with ROTHMUND THOMSON syndorome (poikioderma rash, absent eyelashes, hair)
Prog: 75% long term survival
Worse prognosis with: Advanced stage of dz (most predictive)*** Response to chemo High serum alk phosphatase*** high LDH***
Treatment for osteosarcoma?
Multi-agent chem and limb salvage***
Chemo for 8-12 wks preop and then 6-12 months postop
Wide surgical resection only –> low grade osteosarcoma such as PAROSTEAL osteosarcoma
Parosteal osteosarcoma
Where?
Grade?
Prognosis?
Histo?
Tx?
Posterior distal femur, proximal tibia, and proximal humerus (80% occur in femur)**
Low grade osteosarcoma***
Prognosis –> 95% long term survival
Dedifferential is poor pronsijoc factor
Invasion into medullary cavity does NOT AFFECT LONG TERM SURVIVAL***
Histo: Low grade
High rate of MDM2 amplification* and ring chromosomes*
Tx: wide local surgical excision*
Chemo NOT indicated unless high grade
Periosteal osteosarcoma
Grade?
where?
Genetics?
Prog?
Imaging?
Tx?
Grade: intermediate surface osteosarcoma
Where: diaphysis of long bones (femur and tibia most common)
Genetics: mutation of p53 in 15-20%*
Ass’d with Li-Fraumeni syndrome
Prog: 20-35% chance of pulmonary mets***
Intermediate prog between parosteal and intramedullary osteosarcoma
Imaging: classic “sunburst” or “hair on end” periosteal reaction ***
Tx: same as intramedullary osteosarcoma (chemo-surgery-chemo)
What is most common bone tumor of hand?
Enchondroma***
Ollier’s dz?
Skeletal dysplasia w/ failure of normal endochondral ossification
Enchondromas throughout the metaphyses and diaphyses of long bones
Risk of malignant transformation = 30%***
Mafucci’s syndrome?
Multiple enchondromas AND soft tissue angiomas***
enchondromas markedly expand the bone and angiomas seen as small, round calcified phleboliths***
Risk of malignant transformation = 100%***
Also risk of visceral malignancies (GI etc)**
Tx for enchondromas?
Observation –> tx for vast majority***
Serial XR at 6 mo and 12 mo to confirm no change
Intralesional curettage and bone grafting
For lesions that change on serial XR
Symptomatic lesions
Path fx –> IMMEDIATE curettage and grafting
Osteoblastoma
Size?
Where?
Ass’d condition?
Sx?
Tx?
Size: Nidus >2 cm***
Where: Most common in posterior elements of spine* (50% spine lesions have neuro sx*)
Ass’d condition: Secondary ABC in 10-40%**
Sx: pain, not relieved with NSAIDs
50% lesions in spine have neuro sx***
Tx: Operative, curettage or marginal excision w/ bone grafting*
Recurrence 10-20%
Chondroblastoma - where?
Metastatic potential?
Sx?
XR?
Histo?
Tx?
Epiphyseal lesion in young patient (usually <12 y/o)*
Proximal tibia»>proximal humerus etc
Usually epiphyseal, but CAN CROSS PHYSIS*
Metastatic: <1% develop benign pulmonary mets (similar to GCT)**
Sx: Progressive pain at tumor site
XR: Well circumscribed EPIPHYSEAL LYTIC lesion***
Sharply demarcated, may cross to metaphysis
Cortical expansion may be present
Marrow edema (like osteoid osteoma) on advanced imaging***
GET CHEST XR*** (benign pulmonary mets, like GCT)
Histo: Chondroblasts arranged in “Chickenwire” or “cobblestone” pattern
1/3 have secondary ABC
Tx: Extended intralesional curettage and bone grafting***
Multiple hereditary exostosis (MHE) –> where is pathology?
Inheritance?
Mutation?
Which mutation is most severe?
Chance of malignancy?
Mutations affect eh PREHYPERTROPHIC CHONDROCYTES of physis***
Inheritance: Autosomal dominant
Mutation: EXT1, EXT2, EXT3 (tumor suppressor genes)*
Leads to DECREASED production of HEPARIN SULFATE by chondrocytes found at physis*
Most severe: EXT1 mutations*** more likely to get chondrosarcoma, more exostoses
Chance of malignancy: 5-10% Chance of transformation to chondrosarcoma***
Higher chance of chondrosarcoma in adults if carriage cap >2cm***
Limb deformities in MHE?
Most common in knee, forearm, ankle
Femoral shortening and LLD**
Coxa valga
Knee valgus* (shortened fibula and patellar dislocation)
Ankle valgus* (shortened fibula)
UE
Ulnar shortening*
Radial bowing and radial head dislocation*
Ulnar shortening and ulnar deviation of hand***
Prognosis for chondrosarcoma?
Histo grade correlates w/ survival
Gr I: 90% 5 year survival
Gr II: 60-75%
Gr III: 30-50%
De-diff: <10%
Increased TELOMERASE ACTIVITY –> determined by reverse transcriptase PCR shown to directly correlate with RATE OF RECURRENCE***
Get chest CT**
Multiple myeloma
what types of chains produced?
Labs?
Neoplastic plasma cells produce immunoglobulins:
Heavy chains: IgG (52%)***, IgA (21%), IgM (12%)
Light chains: kappa and lambda
AKA Bence Jones protein
Labs:
Anemia*
Elevated Cr*
Hyper Ca* –> excessive bone respiration
SPEP* –> M spike present*** (50% IgG, 25% IgA)
Beta-2 microglobulin –> marker of dz severity/prognosis
Urine: UPEP –> shows BENCE JONES PROTEIN –> secreted immunoglobulin kappa and lambda light chains***